BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.66% |
| 2 | Healthcare | 6.66% |
| 3 | Financials | 5.71% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Communication Services | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Ascent Industries
ACNT
$135M
| $22.5K | ﹤0.01% |
2,582
+588
| +29% | +$7.08K |
|
3727
EVI Industries
EVI
$209M
| $22.5K | ﹤0.01% |
1,428
+799
| +127% | +$18K |
|
3728
Seaboard Corp
SEB
$4.02B
| $22.5K | ﹤0.01% |
8
-4
| -33% | -$14.5K |
|
|
CRON
3729
Cronos Group
CRON
$1.17B
| $22.5K | ﹤0.01% |
3,963
-23,825
| -86% | -$158K |
|
|
STEX
3730
Streamex Corp
STEX
$90.6M
| $22.5K | ﹤0.01% |
536
+315
| +143% | +$14.1K |
|
3731
NN Inc
NNBR
$296M
| $22.4K | ﹤0.01% |
12,976
+2,707
| +26% | +$19.4K |
|
|
AHT
3732
Ashford Hospitality Trust
AHT
$20.1M
| $22.4K | ﹤0.01% |
30
+10
| +50% | +$20.8K |
|
3733
Barnes & Noble Education
BNED
$424M
| $22.3K | ﹤0.01% |
164
+11
| +7% | +$3.5K |
|
3734
Concrete Pumping Holdings
BBCP
$477M
| $22.3K | ﹤0.01% |
7,807
+4,040
| +107% | +$19.5K |
|
3735
Evolution Petroleum
EPM
$134M
| $22.1K | ﹤0.01% |
8,449
+4,169
| +97% | +$18.9K |
|
|
SBT
3736
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $22K | ﹤0.01% |
5,114
+1,034
| +25% | +$6.72K |
|
|
GEN
3737
DELISTED
Genesis Healthcare, Inc.
GEN
| $21.9K | ﹤0.01% |
25,955
+14,531
| +127% | +$20.8K |
|
|
AGS
3738
DELISTED
PlayAGS
AGS
| $21.8K | ﹤0.01% |
8,221
+4,350
| +112% | +$35.8K |
|
|
AKRX
3739
DELISTED
Akorn Inc
AKRX
| $21.8K | ﹤0.01% |
38,797
+14,440
| +59% | +$16.7K |
|
|
KLDO
3740
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $21.6K | ﹤0.01% |
3,509
+1,857
| +112% | +$12.1K |
|
3741
Reading International Class A
RDI
$33.8M
| $21.5K | ﹤0.01% |
5,534
+1,559
| +39% | +$13.2K |
|
|
CMRX
3742
DELISTED
Chimerix, Inc.
CMRX
| $21.5K | ﹤0.01% |
14,931
+3,270
| +28% | +$5.72K |
|
3743
PUT
Fox Class A
FOXA
$27.4B
| $21.3K | ﹤0.01% |
9
| – | – |
|
3744
Rayonier Advanced Materials
RYAM
$570M
| $21.2K | ﹤0.01% |
20,037
-14
| -0.1% | -$36 |
|
|
ONIT
3745
Onity Group
ONIT
$327M
| $21.1K | ﹤0.01% |
2,812
+310
| +12% | +$5.51K |
|
|
SBBP
3746
DELISTED
Strongbridge Biopharma plc.
SBBP
| $21.1K | ﹤0.01% |
11,138
+2,500
| +29% | +$6.5K |
|
3747
Lifetime Brands
LCUT
$223M
| $21K | ﹤0.01% |
3,722
+839
| +29% | +$5.45K |
|
3748
BioLife Solutions
BLFS
$1.72B
| $20.9K | ﹤0.01% |
2,202
+1,248
| +131% | +$17.1K |
|
|
TYME
3749
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $20.8K | ﹤0.01% |
18,890
+10,173
| +117% | +$13.7K |
|
|
ADMS
3750
DELISTED
Adamas Pharmaceuticals
ADMS
| $20.8K | ﹤0.01% |
7,182
+1,534
| +27% | +$6.88K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.